Beta Bionics, Inc.

NASDAQ:BBNX

Medical - Equipment & Services

Healthcare
$14.33 +3.18%

+$0.42 today

Market cap
$644.70M
Beta
3.39
P/E (TTM)
-9.1
EPS (TTM)
-$1.50
52W Low $8.80High $32.71

Volume 1.38M

Average 0.99M

BBNX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Beta Bionics, Inc.NASDAQ: BBNX

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 44.44M shares rose 44.7% year over year, ahead of the +7.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 9.6% from the prior quarter. Over 3 fiscal years it compounded at +100.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +44.7% holds above the trailing-twelve-month pace of +7.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
44.44M+9.6% QoQ
Last fiscal yearDec 2025
40.53M+536.7% YoY
LTMMar 2026
43M+7.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+44.7%——
1 year+536.7%——
3-year CAGR+100.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
40.53M USD
Year-over-year change
+536.7%
3-year CAGR
+100.9%

Weighted Avg Shares vs competitors

How BBNX compares with its peers on the latest reported figures

  • BBNX's LTM Mar 2026 weighted avg shares of 43M shares is the 7th highest of the 8 companies compared; the peer median is 207.48M shares.
  • Its year-over-year change of +7.0% is the 2nd highest of 7, against a peer median of +0.7%.
  • Over three fiscal years its annual growth of +100.9% compares with a peer median of +0.5%.
BBNX Competitors Peer median
Weighted Avg Shares for BBNX and competitors
Company Period LTM YoY 3-year CAGR
NVONovo Nordisk A/SLTM Jun 20264.44B -0.2%-0.6%
DXCMDexCom, Inc.LTM Jun 2026386.65M -1.9%+0.1%
MNKDMannKind CorporationLTM Mar 2026306.42M +8.4%+5.9%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026207.48M —-3.0%
PODDInsulet CorporationLTM Jun 202670.07M -0.2%+0.5%
TNDMTandem Diabetes Care, Inc.LTM Mar 202667.78M +3.1%+1.6%
BBNXBeta Bionics, Inc.LTM Mar 202643M +7.0%+100.9%
ORMPOramed Pharmaceuticals Inc.LTM Mar 202641.42M +1.6%+2.0%
Peer median (excluding BBNX) 207.48M+0.7%+0.5%

Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue179K12M65.12M100.25M
Cost of Revenue05.69M29.24M44.71M
Gross Profit179K6.31M35.89M55.54M
Gross Margin100.0%52.6%55.1%55.4%
Research & Development31.43M17.94M26.18M34.79M
Selling, General & Admin33.5M24.22M54.96M92.43M
Operating Expenses66.02M42.16M81.14M127.22M
Depreciation & Amortization1.35M1.23M1.15M2.88M
EBITDA(63.4M)(42.87M)(53.61M)(70.32M)
EBITDA Margin-35418.4%-357.4%-82.3%-70.1%
Operating Income(65.84M)(35.85M)(45.25M)(71.68M)
Operating Margin-36784.4%-298.9%-69.5%-71.5%
Interest Income196K1.78M3.91M10.93M
Interest Expense14K000
Other Income / Expenses1.09M(8.25M)(9.51M)(1.52M)
Income Before Tax(64.75M)(44.1M)(54.76M)(73.2M)
Pre-Tax Margin-36173.7%-367.6%-84.1%-73.0%
Income Tax Expense0001K
Net Income(64.75M)(44.1M)(54.76M)(73.2M)
Net Margin-36173.7%-367.6%-84.1%-73.0%
EPS (Basic)(12.96)(8.31)(8.60)(1.81)
EPS (Diluted)(12.96)(8.31)(8.60)(1.81)
Weighted Avg Shares5M5.3M6.37M40.53M
Weighted Avg Shares (Diluted)5M5.3M6.37M40.53M

Beta Bionics, Inc.

NASDAQ:BBNX

Intrinsic Alpha fair value

Locked

Current Price

$14.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.